Skip to content 
Global markets are walking into the week with a familiar problem and a new trigger. Oil is back above $100 and geopolitics is back at the center of price discovery.
U.S. stock futures are pointing lower this morning. Dow futures are down about 430 points, while S&P 500 and Nasdaq 100 futures are also in the red. The catalyst is not earnings. It is the sudden escalation in the Middle East after President Donald Trump announced a naval blockade targeting Iran-linked shipping through the Strait of Hormuz.
This is not just another headline risk. The Strait of Hormuz is one of the most critical arteries for global oil supply. Any disruption here quickly feeds into energy prices, inflation expectations, and eventually equity valuations.
Oil reacted instantly. West Texas Intermediate jumped over 7% to cross $103 per barrel, while Brent crude also surged past $101. That move alone is enough to change how investors think about growth, margins, and central bank policy over the next few months.
Think of it like this. Markets were pricing in a gradual normalization after last week’s ceasefire optimism. Now they are being forced to reprice a longer conflict scenario.
The volatility gauge, the VIX, is back above 20. Not panic territory, but clearly signaling rising nervousness.
Earnings start strong, but markets are not impressed
First quarter earnings season kicked off with a paradox.
Goldman Sachs delivered a clean beat on both revenue and profits, driven by strong equities trading and better investment banking activity. Yet the stock fell more than 2% in premarket trading.
The reason is simple. Markets are forward looking and selective. Goldman’s fixed income trading came in below expectations, and that was enough to overshadow an otherwise strong quarter.
This is a pattern investors should watch closely this season. In a fragile macro environment, good is not enough. Companies need to exceed expectations across segments to sustain rallies.
Healthcare surprise lights up biotech
While banks struggled to impress, biotech delivered a breakout moment.
Revolution Medicines surged over 37% after its pancreatic cancer drug showed strong results in a late stage trial. Patients on the drug lived nearly twice as long compared to those on chemotherapy.
In a market dominated by macro headlines, stock specific breakthroughs like this still matter. They remind investors that innovation can create pockets of outsized returns even in uncertain times.
Sector rotation driven by oil
The sharp move in oil is already reshaping sector performance.
Energy stocks are rallying as higher crude prices directly boost earnings expectations. Companies like Chevron and Exxon Mobil are trading higher in premarket action.
On the flip side, sectors sensitive to fuel costs are under pressure.
Airlines and cruise companies are falling as rising jet fuel and operating costs threaten margins and demand. Stocks like United Airlines, Delta Air Lines, and Carnival are all trading lower.
This is classic second order market behavior. Oil goes up, energy wins, transport loses.
Other notable movers
Williams Sonoma is seeing strength after an upgrade, signaling that select retail names still have valuation support.
Best Buy is under pressure following a downgrade, with concerns around demand sustainability once short term boosts fade.
Homebuilders like Toll Brothers and PulteGroup are catching bids as analysts argue the worst may already be priced in.
Fastenal slipped despite meeting expectations, another reminder that meeting estimates is no longer enough in this market.
Palantir is attempting a rebound after last week’s sharp selloff tied to AI disruption fears.
Leggett and Platt jumped after announcing a $2.5 billion acquisition deal, showing that M&A activity is still alive despite macro uncertainty.
Snapshot of Key Movers
| Segment | Winners | Losers | Why it matters |
| Energy | Chevron, Exxon Mobil, APA | Airlines, Cruise lines | Oil above $100 reshapes margins |
| Biotech | Revolution Medicines | – | Breakthrough trial result |
| Financials | Goldman Sachs (earnings beat) | Goldman Sachs (stock down) | Segment miss outweighs overall beat |
| Retail | Williams Sonoma | Best Buy | Analyst upgrades vs demand concerns |
| Industrials | – | Fastenal | Expectations bar remains high |
The bigger picture
Last week, markets rallied on hopes of de-escalation. This week, they are back to pricing uncertainty.
The key question now is not just how high oil goes. It is how long it stays elevated.
If crude sustains above $100, it could ripple through inflation, delay rate cuts, and compress equity valuations. If tensions cool quickly, this could turn into another short-lived spike.
For now, markets are doing what they do best. Reassessing risk in real time.
